Mellitor

Company Overview

Snapshot

Founded in September 2006 by Doron Goldberg, Mellitor operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of an implantable glucose sensor. Mellitor holds one patent, underscoring its commitment to proprietary technology in the medical device sector.

Business overview

Mellitor specializes in developing an implantable glucose sensor for continuous monitoring in diabetic patients. The core technology involves a sensor designed for extended implantation, similar to a pacemaker, providing real-time and highly accurate glucose level measurements in interstitial fluid. Additionally, Mellitor leverages its technology for the development of an HPLC polarimeter, serving the Health Tech & Life Sciences sector, specifically targeting medical devices and monitoring for chronic patients and healthcare providers.

Company Intelligence Q&A

What is Mellitor's primary product focus?

Mellitor is developing an implantable glucose sensor for the continuous monitoring of glucose levels in patients with diabetes. This sensor is designed for extended implantation and provides real-time, accurate measurements.

Who founded Mellitor?

Mellitor was co-founded by Doron Goldberg, who serves as the CTO.

In which sector does Mellitor primarily operate?

Mellitor operates within the Health Tech & Life Sciences sector, with a specific focus on medical devices and monitoring technologies.

What is the current development stage of Mellitor's products?

Mellitor's products are currently in the R&D stage, focusing on advancing its implantable glucose sensor technology.

Does Mellitor hold any patents?

Yes, Mellitor holds one patent related to its technology, indicating its focus on proprietary innovation in the medical device space.